Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Achievement of glycaemic targets with weight loss and without hypoglycaemia in type 2 diabetes with the once-weekly glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist tirzepatide: A post hoc analysis of the SURPASS-1 to -5 studies.
Lingvay I, Cheng AY, Levine JA, Gomez-Valderas E, Allen SE, Ranta K, Torcello-Gómez A, Thieu VT. Lingvay I, et al. Among authors: thieu vt. Diabetes Obes Metab. 2023 Apr;25(4):965-974. doi: 10.1111/dom.14943. Epub 2022 Dec 27. Diabetes Obes Metab. 2023. PMID: 36514843 Clinical Trial.
Relationship between body weight change and glycaemic control with tirzepatide treatment in people with type 2 diabetes: A post hoc assessment of the SURPASS clinical trial programme.
Pedersen SD, Giorgino F, Umpierrez G, Thieu VT, Rodríguez A, Nicolay C, Fernández Landó L, Karanikas CA, Kiljanski J. Pedersen SD, et al. Among authors: thieu vt. Diabetes Obes Metab. 2023 Sep;25(9):2553-2560. doi: 10.1111/dom.15140. Epub 2023 May 29. Diabetes Obes Metab. 2023. PMID: 37246796
33 results